Lv5
980 积分 2024-03-19 加入
Inavolisib (Itovebi) for Locally Advanced or Metastatic Breast Cancer
10天前
已关闭
Electronic patient-reported outcome measures (ePROs) as tools for assessing health-related quality of life (HRQoL) in women with gynecologic and breast cancers: a systematic review
11天前
已完结
Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human
22天前
已完结
Comparative molecular dynamics analyses on PIK3CA hotspot mutations with PI3Kα specific inhibitors and ATP
22天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
22天前
已完结
Phase III trial of chemotherapy ? HerceptinR in metastatic breast cancer
1个月前
已完结
Iruplinalkib: First Approval
1个月前
已完结
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
2个月前
已完结
Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report
2个月前
已完结
Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer
3个月前
已关闭
皖公网安备34019202002308
